Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)
China · Delayed Price · Currency is CNY 4.790
+0.030 (0.63%)
Jul 3, 2026, 3:00 PM CST
SHA:603567 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,498 | 8,388 | 10,897 | 11,423 | 11,988 | 14,412 | |
Market Cap Growth | -57.43% | -23.03% | -4.61% | -4.71% | -16.82% | 52.08% |
Enterprise Value | 7,624 | 11,472 | 13,767 | 13,636 | 13,478 | 17,271 |
Last Close Price | 4.79 | 8.93 | 11.46 | 11.80 | 12.35 | 14.68 |
PE Ratio | - | - | 24.87 | 24.16 | 64.65 | 43.40 |
Forward PE | - | 36.69 | 36.69 | 36.69 | 36.69 | 36.69 |
PS Ratio | 8.82 | 10.52 | 4.03 | 3.64 | 2.85 | 3.49 |
PB Ratio | 0.73 | 1.34 | 1.31 | 1.42 | 1.69 | 2.04 |
P/TBV Ratio | 0.89 | 1.61 | 1.60 | 1.69 | 1.90 | 2.12 |
P/FCF Ratio | 7.47 | 33.08 | - | - | - | - |
P/OCF Ratio | 6.89 | 26.04 | 66.32 | - | - | - |
EV/Sales Ratio | 14.95 | 14.39 | 5.09 | 4.35 | 3.20 | 4.18 |
EV/EBITDA Ratio | - | - | 18.55 | 37.43 | - | 42.55 |
EV/EBIT Ratio | - | - | 22.83 | 73.50 | - | 63.88 |
EV/FCF Ratio | 12.66 | 45.24 | - | - | - | - |
Debt / Equity Ratio | 0.51 | 0.50 | 0.40 | 0.39 | 0.41 | 0.42 |
Debt / EBITDA Ratio | - | - | 4.41 | 8.38 | - | 7.23 |
Debt / FCF Ratio | 5.23 | 12.30 | - | - | - | - |
Net Debt / Equity Ratio | 0.50 | 0.48 | 0.27 | 0.21 | 0.26 | 0.20 |
Net Debt / EBITDA Ratio | -2.39 | -3.17 | 3.00 | 4.62 | -31.21 | 3.40 |
Net Debt / FCF Ratio | 5.13 | 11.97 | -89.56 | -2.93 | -2.55 | -1.56 |
Asset Turnover | 0.04 | 0.07 | 0.22 | 0.26 | 0.36 | 0.38 |
Inventory Turnover | 0.84 | 0.85 | 1.21 | 2.14 | 4.07 | 3.34 |
Quick Ratio | 0.86 | 0.81 | 2.11 | 2.16 | 1.27 | 2.04 |
Current Ratio | 1.38 | 1.26 | 2.85 | 2.60 | 1.65 | 2.37 |
Return on Equity (ROE) | -22.41% | -18.80% | 5.34% | 6.17% | 2.70% | 5.30% |
Return on Assets (ROA) | -7.85% | -6.01% | 2.99% | 0.96% | -1.17% | 1.55% |
Return on Invested Capital (ROIC) | -15.82% | -11.33% | 4.97% | 1.94% | -1.59% | 2.54% |
Return on Capital Employed (ROCE) | -21.40% | -17.20% | 5.90% | 1.90% | -2.80% | 3.10% |
Earnings Yield | -36.05% | -16.29% | 4.02% | 4.14% | 1.55% | 2.30% |
FCF Yield | 13.38% | 3.02% | -0.23% | -5.02% | -6.10% | -6.12% |
Dividend Yield | 3.15% | - | 1.31% | 1.70% | 0.23% | 0.72% |
Payout Ratio | - | - | 74.00% | 33.48% | 131.34% | 43.28% |
Buyback Yield / Dilution | 0.05% | 0.01% | 0.01% | 0.14% | -8.87% | -1.82% |
Total Shareholder Return | 3.20% | 0.01% | 1.31% | 1.83% | -8.64% | -1.10% |